All Posts: breast cancer
-
Women with Elevated Breast Cancer Risk Could See Mortality Benefit from Estrogen-Blocking Drugs
WASHINGTON (Thursday, December 1, 2022) — While it has long been recognized that drugs that block the cancer-promoting activity of estrogen reduce the risk of developing new breast cancers, a new computer modeling study led by researchers at Georgetown Lombardi Comprehensive Cancer Center and colleagues showed that these treatments could also reduce the risk of […]
Category: News Release
-
Study in Mice Suggests that Expression of Estrogen-Related Gene Can Impact Postmenopausal Breast Cancer Risk and Prevention Strategies
WASHINGTON (December 1, 2022) — In a study using a first-of-its-kind mouse model of aging that mimics breast cancer development in estrogen receptor-positive postmenopausal women, investigators at Georgetown Lombardi Comprehensive Cancer Center and colleagues have determined that over-expression, or switching on, of the Esr1 gene could lead to elevated risk of developing estrogen receptor-positive breast […]
Category: News Release
-
‘Lombardi Women’ Event Brings Together Local Businesswomen to Support Breast Cancer Research
(October 7, 2022) — Held in person for the first time since 2019, the 16th Annual Lombardi Women event brought together 450 businesswomen and 43 sponsoring companies from across the Washington area. The event took place October 6 at the Pavilions at Wolf Trap National Park. “For 16 years, this group of women has come […]
Category: Lombardi Stories
-
Long-term Study Supports Link Between Inflammation and Cognitive Problems in Older Breast Cancer Survivors
Researchers followed hundreds of survivors for years to examine suspected source of worrying symptoms. LOS ANGELES (September 30, 2022) — Scientists are still trying to understand why many breast cancer survivors experience troubling cognitive problems for years after treatment. Inflammation is one possible culprit. A new long-term study of older breast cancer survivors, published today […]
Category: News Release
-
Technique Developed in Mice Could Aid Detection of Cancer in Dense Breasts
WASHINGTON (September 14, 2022) — A two-pronged approach to imaging breast density in mice, developed by researchers at Georgetown Lombardi Comprehensive Cancer Center, resulted in better detection of changes in breast tissue, including spotting early signs of cancer. The researchers hope that this approach will be translated from mice and improve breast imaging for people; […]
Category: News Release
-
Informing Children of a Mother’s Genetic Cancer Risk Does Not Impact Their Health Behaviors
WASHINGTON (July 21, 2022) — Telling a child about their mother’s risk of hereditary breast and ovarian cancer does not adversely influence the offspring’s lifestyle or quality of life in the long term, according to a new study led by researchers at Georgetown Lombardi Comprehensive Cancer Center. The finding appeared July 21, 2022, in Pediatrics […]
Category: News Release
-
Ralph Lauren Corporate Foundation Makes Gift to Address Disparities in Cancer Care
Category: Lombardi Stories
-
Ralph Lauren Corporate Foundation Announces $25 Million Commitment to Five Cancer Centers Across America With Goal of Reducing Disparities in Cancer Care in Underserved Communities
Commitment Recognized by White House Cancer Moonshot Georgetown University to establish The Ralph Lauren Center for Cancer Prevention at Georgetown Lombardi Comprehensive Cancer Center in Washington, D.C. Memorial Sloan Kettering (MSK) Ralph Lauren Center to build upon 20-year partnership serving Harlem, New York, and surrounding communities Conquer Cancer®, the ASCO Foundation, to collaborate on the […]
Category: News Release
-
Study Shows Sleep Disturbances During the Pandemic Were Similar between Breast Cancer Survivors and Healthy Controls
WASHINGTON (May 2, 2022) — Results from the Thinking and Living with Cancer Study (TLC) showed that the development of sleep disturbances during the early months of the COVID-19 pandemic increased symptoms of depression and anxiety among older women, but the findings did not differ between women who survived breast cancer and women without cancer. […]
Category: News Release
-
New Factors That Can Predict Breast Cancer Recurrence Defined
Discovery Has the Potential to Also Benefit Treatment Choices. WASHINGTON (April 22, 2022) — Genetics and other factors that can determine if a woman is at risk for a recurrence of breast cancer have been identified by investigators at Georgetown Lombardi Comprehensive Cancer Center, providing new research avenues for preventing a new tumor from developing. […]
Category: News Release